{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:32:43Z","timestamp":1770823963422,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T00:00:00Z","timestamp":1251158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00428-009-0821-z","type":"journal-article","created":{"date-parts":[[2009,8,24]],"date-time":"2009-08-24T08:37:26Z","timestamp":1251103046000},"page":"277-284","source":"Crossref","is-referenced-by-count":51,"title":["Loss of RKIP expression is associated with poor survival in GISTs"],"prefix":"10.1007","volume":"455","author":[{"given":"Olga","family":"Martinho","sequence":"first","affiliation":[]},{"given":"Ant\u00f3nio","family":"Gouveia","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Amadeu","family":"Pimenta","sequence":"additional","affiliation":[]},{"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Lopes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,8,25]]},"reference":[{"key":"821_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.21167","volume":"117","author":"G Tryggvason","year":"2005","unstructured":"Tryggvason G, Gislason HG, Magnusson MK et al (2005) Gastrointestinal stromal tumors in Iceland, 1990\u20132003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer 117:289\u2013293","journal-title":"Int J Cancer"},{"key":"821_CR2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/cncr.20862","volume":"103","author":"B Nilsson","year":"2005","unstructured":"Nilsson B, Bumming P, Meis-Kindblom JM et al (2005) Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era\u2014a population-based study in western Sweden. Cancer 103:821\u2013829","journal-title":"Cancer"},{"key":"821_CR3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577\u2013580","journal-title":"Science"},{"key":"821_CR4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","volume":"299","author":"MC Heinrich","year":"2003","unstructured":"Heinrich MC, Corless CL, Duensing A et al (2003) PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299:708\u2013710","journal-title":"Science"},{"key":"821_CR5","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2002.20.6.1692","volume":"20","author":"MC Heinrich","year":"2002","unstructured":"Heinrich MC, Blanke CD, Druker BJ et al (2002) Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 20:1692\u20131703","journal-title":"J Clin Oncol"},{"key":"821_CR6","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","volume":"21","author":"MC Heinrich","year":"2003","unstructured":"Heinrich MC, Corless CL, Demetri GD et al (2003) Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21:4342\u20134349","journal-title":"J Clin Oncol"},{"key":"821_CR7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/jcp.2005.031112","volume":"59","author":"L Tornillo","year":"2006","unstructured":"Tornillo L, Terracciano LM (2006) An update on molecular genetics of gastrointestinal stromal tumours. J Clin Pathol 59:557\u2013563","journal-title":"J Clin Pathol"},{"key":"821_CR8","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.5858\/2006-130-1466-GSTROM","volume":"130","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130:1466\u20131478","journal-title":"Arch Pathol Lab Med"},{"key":"821_CR9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.pathmechdis.3.121806.151538","volume":"3","author":"CL Corless","year":"2008","unstructured":"Corless CL, Heinrich MC (2008) Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol 3:557\u201386","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"821_CR10","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00268-008-9704-8","volume":"32","author":"AM Gouveia","year":"2008","unstructured":"Gouveia AM, Pimenta AP, Capelinha AF et al (2008) Surgical margin status and prognosis of gastrointestinal stromal tumor. World J Surg 32(11):2375\u201382","journal-title":"World J Surg"},{"key":"821_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10147-007-0705-7","volume":"12","author":"T Takahashi","year":"2007","unstructured":"Takahashi T, Nakajima K, Nishitani A et al (2007) An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors. Int J Clin Oncol 12:369\u2013374","journal-title":"Int J Clin Oncol"},{"key":"821_CR12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00428-007-0473-9","volume":"451","author":"E Wardelmann","year":"2007","unstructured":"Wardelmann E, Buttner R, Merkelbach-Bruse S et al (2007) Mutation analysis of gastrointestinal stromal tumors: increasing significance for risk assessment and effective targeted therapy. Virchows Arch 451:743\u2013749","journal-title":"Virchows Arch"},{"key":"821_CR13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.11323","volume":"106","author":"E Wardelmann","year":"2003","unstructured":"Wardelmann E, Losen I, Hans V et al (2003) Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors. Int J Cancer 106:887\u2013895","journal-title":"Int J Cancer"},{"key":"821_CR14","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","volume":"26","author":"AS Dhillon","year":"2007","unstructured":"Dhillon AS, Hagan S, Rath O et al (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279\u20133290","journal-title":"Oncogene"},{"key":"821_CR15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/gcc.20589","volume":"47","author":"NP Agaram","year":"2008","unstructured":"Agaram NP, Wong GC, Guo T et al (2008) Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosomes Cancer 47:853\u2013859","journal-title":"Genes Chromosomes Cancer"},{"key":"821_CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2559.2009.03323.x","volume":"55","author":"O Martinho","year":"2009","unstructured":"Martinho O, Gouveia A, Viana-Pereira M et al (2009) Low frequency of MAP kinase signalling pathway alterations in KIT & PDGFRA wild-type GISTs. Histopathology 55:53\u201362","journal-title":"Histopathology"},{"key":"821_CR17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/43686","volume":"401","author":"K Yeung","year":"1999","unstructured":"Yeung K, Seitz T, Li S et al (1999) Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401:173\u2013177","journal-title":"Nature"},{"key":"821_CR18","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1128\/MCB.20.9.3079-3085.2000","volume":"20","author":"K Yeung","year":"2000","unstructured":"Yeung K, Janosch P, McFerran B et al (2000) Mechanism of suppression of the Raf\/MEK\/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 20:3079\u20133085","journal-title":"Mol Cell Biol"},{"key":"821_CR19","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1128\/MCB.21.21.7207-7217.2001","volume":"21","author":"KC Yeung","year":"2001","unstructured":"Yeung KC, Rose DW, Dhillon AS et al (2001) Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 21:7207\u20137217","journal-title":"Mol Cell Biol"},{"key":"821_CR20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nature02158","volume":"426","author":"K Lorenz","year":"2003","unstructured":"Lorenz K, Lohse MJ, Quitterer U (2003) Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426:574\u2013579","journal-title":"Nature"},{"key":"821_CR21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/jcp.2007.046987","volume":"61","author":"F Al-Mulla","year":"2008","unstructured":"Al-Mulla F, Hagan S, Al-Ali W et al (2008) Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 61:524\u2013529","journal-title":"J Clin Pathol"},{"key":"821_CR22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bcp.2004.04.024","volume":"68","author":"ET Keller","year":"2004","unstructured":"Keller ET, Fu Z, Brennan M (2004) The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 68:1049\u20131053","journal-title":"Biochem Pharmacol"},{"key":"821_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2007.07.003","volume":"20","author":"J Klysik","year":"2008","unstructured":"Klysik J, Theroux SJ, Sedivy JM et al (2008) Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 20:1\u20139","journal-title":"Cell Signal"},{"key":"821_CR24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0167-4838(84)90221-8","volume":"790","author":"I Bernier","year":"1984","unstructured":"Bernier I, Jolles P (1984) Purification and characterization of a basic 23\u00a0kDa cytosolic protein from bovine brain. Biochim Biophys Acta 790:174\u2013181","journal-title":"Biochim Biophys Acta"},{"key":"821_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0378-1119(94)90562-2","volume":"140","author":"N Hori","year":"1994","unstructured":"Hori N, Chae KS, Murakawa K et al (1994) A human cDNA sequence homologue of bovine phosphatidylethanolamine-binding protein. Gene 140:293\u2013294","journal-title":"Gene"},{"key":"821_CR26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF00160411","volume":"39","author":"N Seddiqi","year":"1994","unstructured":"Seddiqi N, Bollengier F, Alliel PM et al (1994) Amino acid sequence of the Homo sapiens brain 21\u201323-kDa protein (neuropolypeptide h3), comparison with its counterparts from Rattus norvegicus and Bos taurus species, and expression of its mRNA in different tissues. J Mol Evol 39:655\u2013660","journal-title":"J Mol Evol"},{"key":"821_CR27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jnci\/95.12.878","volume":"95","author":"Z Fu","year":"2003","unstructured":"Fu Z, Smith PC, Zhang L et al (2003) Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95:878\u2013889","journal-title":"J Natl Cancer Inst"},{"key":"821_CR28","doi-asserted-by":"crossref","first-page":"17515","DOI":"10.1074\/jbc.M313816200","volume":"279","author":"D Chatterjee","year":"2004","unstructured":"Chatterjee D, Bai Y, Wang Z et al (2004) RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 279:17515\u201317523","journal-title":"J Biol Chem"},{"key":"821_CR29","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1158\/0008-5472.CAN-03-3861","volume":"64","author":"MM Schuierer","year":"2004","unstructured":"Schuierer MM, Bataille F, Hagan S et al (2004) Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 64:5186\u20135192","journal-title":"Cancer Res"},{"key":"821_CR30","first-page":"451","volume":"16","author":"MM Schuierer","year":"2006","unstructured":"Schuierer MM, Bataille F, Weiss TS et al (2006) Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep 16:451\u2013456","journal-title":"Oncol Rep"},{"key":"821_CR31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.surg.2003.12.013","volume":"136","author":"L Zhang","year":"2004","unstructured":"Zhang L, Fu Z, Binkley C et al (2004) Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery 136:708\u2013715","journal-title":"Surgery"},{"key":"821_CR32","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1158\/1078-0432.CCR-05-0283","volume":"11","author":"S Hagan","year":"2005","unstructured":"Hagan S, Al-Mulla F, Mallon E et al (2005) Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11:7392\u20137397","journal-title":"Clin Cancer Res"},{"key":"821_CR33","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/j.gastro.2006.07.012","volume":"131","author":"HC Lee","year":"2006","unstructured":"Lee HC, Tian B, Sedivy JM et al (2006) Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 131:1208\u20131217","journal-title":"Gastroenterology"},{"key":"821_CR34","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1200\/JCO.2006.07.5499","volume":"24","author":"F Al-Mulla","year":"2006","unstructured":"Al-Mulla F, Hagan S, Behbehani AI et al (2006) Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients 1. J Clin Oncol 24:5672\u20135679","journal-title":"J Clin Oncol"},{"key":"821_CR35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1158\/1541-7786.MCR-08-0093","volume":"6","author":"HZ Li","year":"2008","unstructured":"Li HZ, Wang Y, Gao Y et al (2008) Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 6:917\u2013928","journal-title":"Mol Cancer Res"},{"key":"821_CR36","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1158\/1078-0432.CCR-07-4496","volume":"14","author":"D Chatterjee","year":"2008","unstructured":"Chatterjee D, Sabo E, Tavares R et al (2008) Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 14:2994\u20133001","journal-title":"Clin Cancer Res"},{"key":"821_CR37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1158\/1078-0432.CCR-07-1380","volume":"14","author":"I Zlobec","year":"2008","unstructured":"Zlobec I, Baker K, Minoo P et al (2008) Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and raf-1 kinase inhibitor protein expression. Clin Cancer Res 14:143\u2013148","journal-title":"Clin Cancer Res"},{"key":"821_CR38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/pros.20319","volume":"66","author":"Z Fu","year":"2006","unstructured":"Fu Z, Kitagawa Y, Shen R et al (2006) Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66:248\u2013256","journal-title":"Prostate"},{"issue":"10","key":"821_CR39","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/gut.2005.082859","volume":"55","author":"P Minoo","year":"2006","unstructured":"Minoo P, Baker K, Goswami R et al (2006) Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55(10):1467\u20131474","journal-title":"Gut"},{"key":"821_CR40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/106689690201000201","volume":"10","author":"CD Fletcher","year":"2002","unstructured":"Fletcher CD, Berman JJ, Corless C et al (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol 10:81\u201389","journal-title":"Int J Surg Pathol"},{"key":"821_CR41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jcp.2007.047043","volume":"61","author":"AL Gomes","year":"2008","unstructured":"Gomes AL, Gouveia A, Capelinha AF et al (2008) Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series. J Clin Pathol 61:203\u2013208","journal-title":"J Clin Pathol"},{"key":"821_CR42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-004-0936-x","volume":"109","author":"D Basto","year":"2005","unstructured":"Basto D, Trovisco V, Lopes JM et al (2005) Mutation analysis of B-RAF gene in human gliomas. Acta Neuropathol (Berl) 109:207\u2013210","journal-title":"Acta Neuropathol (Berl)"},{"key":"821_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000658-200001000-00008","volume":"231","author":"RP Dematteo","year":"2000","unstructured":"Dematteo RP, Lewis JJ, Leung D et al (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51\u201358","journal-title":"Ann Surg"},{"key":"821_CR44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","volume":"347","author":"GD Demetri","year":"2002","unstructured":"Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472\u2013480","journal-title":"N Engl J Med"},{"key":"821_CR45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/cr.2008.43","volume":"18","author":"AE Granovsky","year":"2008","unstructured":"Granovsky AE, Rosner MR (2008) Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res 18:452\u2013457","journal-title":"Cell Res"},{"key":"821_CR46","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1309\/5D7MM22DAVGDT1R8","volume":"127","author":"P Minoo","year":"2007","unstructured":"Minoo P, Zlobec I, Baker K et al (2007) Loss of Raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol 127:820\u2013827","journal-title":"Am J Clin Pathol"},{"key":"821_CR47","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.jid.5700170","volume":"126","author":"R Houben","year":"2006","unstructured":"Houben R, Michel B, Vetter-Kauczok CS et al (2006) Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma. J Invest Dermatol 126:1135\u20131142","journal-title":"J Invest Dermatol"},{"key":"821_CR48","first-page":"4437","volume":"26","author":"J Akaishi","year":"2006","unstructured":"Akaishi J, Onda M, Asaka S et al (2006) Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancer. Anticancer Res 26:4437\u20134442","journal-title":"Anticancer Res"},{"key":"821_CR49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.molcel.2006.07.015","volume":"23","author":"EM Eves","year":"2006","unstructured":"Eves EM, Shapiro P, Naik K et al (2006) Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell 23:561\u2013574","journal-title":"Mol Cell"},{"key":"821_CR50","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.chembiol.2005.07.007","volume":"12","author":"S Zhu","year":"2005","unstructured":"Zhu S, Mc Henry KT, Lane WS et al (2005) A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration. Chem Biol 12:981\u2013991","journal-title":"Chem Biol"},{"key":"821_CR51","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1158\/0008-5472.CAN-03-3500","volume":"64","author":"AR Jazirehi","year":"2004","unstructured":"Jazirehi AR, Vega MI, Chatterjee D et al (2004) Inhibition of the Raf-MEK1\/2-ERK1\/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Cancer Res 64:7117\u20137126","journal-title":"Cancer Res"},{"key":"821_CR52","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jc.2007-2272","volume":"93","author":"SL Fougner","year":"2008","unstructured":"Fougner SL, Bollerslev J, Latif F et al (2008) Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment. J Clin Endocrinol Metab 93:1211\u20131216","journal-title":"J Clin Endocrinol Metab"},{"key":"821_CR53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.niox.2008.04.018","volume":"19","author":"B Bonavida","year":"2008","unstructured":"Bonavida B, Baritaki S, Huerta-Yepez S et al (2008) Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases. Nitric Oxide 19:152\u2013157","journal-title":"Nitric Oxide"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-009-0821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-009-0821-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-009-0821-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T23:46:32Z","timestamp":1633823192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-009-0821-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,25]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["821"],"URL":"https:\/\/doi.org\/10.1007\/s00428-009-0821-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,25]]}}}